- Home
- TEX vs ZLAB Comparison
TEX vs ZLAB Comparison
Compare TEX & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEX
- ZLAB
- Stock Information
- Founded
- TEX 1933
- ZLAB 2013
- Country
- TEX United States
- ZLAB China
- Employees
- TEX N/A
- ZLAB N/A
- Industry
- TEX Construction/Ag Equipment/Trucks
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- TEX Industrials
- ZLAB Health Care
- Exchange
- TEX Nasdaq
- ZLAB Nasdaq
- Market Cap
- TEX 3.3B
- ZLAB 3.6B
- IPO Year
- TEX N/A
- ZLAB 2017
- Fundamental
- Price
- TEX $52.81
- ZLAB $32.91
- Analyst Decision
- TEX Buy
- ZLAB Buy
- Analyst Count
- TEX 9
- ZLAB 6
- Target Price
- TEX $54.67
- ZLAB $57.22
- AVG Volume (30 Days)
- TEX 618.5K
- ZLAB 725.2K
- Earning Date
- TEX 10-29-2025
- ZLAB 11-11-2025
- Dividend Yield
- TEX 1.27%
- ZLAB N/A
- EPS Growth
- TEX N/A
- ZLAB N/A
- EPS
- TEX 2.67
- ZLAB N/A
- Revenue
- TEX $5,169,000,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- TEX $7.39
- ZLAB $41.60
- Revenue Next Year
- TEX $4.29
- ZLAB $53.42
- P/E Ratio
- TEX $20.05
- ZLAB N/A
- Revenue Growth
- TEX N/A
- ZLAB 32.56
- 52 Week Low
- TEX $31.53
- ZLAB $23.70
- 52 Week High
- TEX $58.66
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- TEX 54.93
- ZLAB 49.59
- Support Level
- TEX $52.24
- ZLAB $33.76
- Resistance Level
- TEX $52.00
- ZLAB $34.72
- Average True Range (ATR)
- TEX 1.41
- ZLAB 0.86
- MACD
- TEX 0.06
- ZLAB 0.20
- Stochastic Oscillator
- TEX 62.82
- ZLAB 51.19
About TEX Terex Corporation
Terex Corp is a manufacturer of materials processing machinery, waste and recycling solutions, mobile elevating work platforms (MEWPs), and equipment for the electric utility industry. The company designs builds, and supports products used in maintenance, manufacturing, energy, waste and recycling, minerals and materials management, construction, and the entertainment industry. The products are manufactured in North America, Europe, and Asia Pacific and sold all over the world. The company reports business in the following segments: (i) Materials Processing, (ii) Aerial Work Platforms, and (iii) Environmental Solutions Group.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.